Oligometastatic Carcinoma — Trials

Oligometastatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 6%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05303714	PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer(PIPAC_VEROne)	recruiting	Phase 3	98	Azienda Ospedaliera Universitaria Integrata VeronaOTHER	1	Feb 21, 2025	clinicaltrials

Data updated 23 days agoSource updated Feb 21, 2025source: clinicaltrials